With issues in therapy delivery and a barren trial landscape, short-term chances for a commercial galactosemia treatment are ...
Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...
Discover how a novel nasal spray could revolutionize traumatic brain injury treatment by reducing neuroinflammation and ...
The nameless disease is neurodegenerative, which means it has no cure, and Ireland could face a gradual decline in her ...
Ocrelizumab treatment in Black and Hispanic patients with MS reduces NfL levels and prevents the forming of contrast-enhancing lesions and new or enlarging T2 lesions.
Understanding the Challenges of Alzheimer’s Disease Alzheimer’s disease doesn’t just impact the person diagnosed—it affects ...
Explore how sexually transmitted infections progress, symptoms to watch for, and prevention strategies to protect sexual ...
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...
A young woman from Wolverhampton, Talia Sinnott, is urgently appealing for community support to fund a life-changing medical ...
The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in ...
Could a social media post really solve years of confusion? Friedrich's Ataxia is a rare disease that only affects 1-in-50,000 people. "Looking at the way this girl moved — the unsteadiness and ...